ConductScience.org, home

Paper40316617

Impact of CYP2D6, MAOA, and UGT2B7 genetic variants on recurrence of Plasmodium Vivax in the Brazilian Amazon.

da Silva GS and 11 others. Sci Rep, 2025. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Impact of CYP2D6, MAOA, and UGT2B7 genetic variants on recurrence of Plasmodium Vivax in the Brazilian Amazon. Papers, record 40316617. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40316617

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Impact of CYP2D6, MAOA, and UGT2B7 genetic variants on recurrence of Plasmodium Vivax in the Brazilian Amazon.
PubMed
Journal
Sci Rep
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
1.85, provisional
iCite
Revised in PubMed
2025-05-05
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1da Silva GSGabrielly S
2Fontenelle FAFlávia A
3Carvalho AOAmanda O
4Macêdo MMMarielle M
5Morais MCManuela C
6Abreu Netto RLRebeca L
7Mwangi VIVictor I
8Alecrim MGCMaria G C
9Lacerda MVGMarcus V G
10Rodrigues-Soares FFernanda
11de Almeida ACGAnne C G
12de Melo GCGisely Cardoso

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cytochrome P-450 CYP2D6Major topic
Malaria, VivaxMajor topic
Plasmodium vivaxMajor topic
GlucuronosyltransferaseMajor topic
Monoamine OxidaseMajor topic
Humans
Brazil
Male
Female
Adult
Case-Control Studies
Recurrence
Primaquine
Genotype
Young Adult
Middle Aged
Alleles
Antimalarials
Adolescent
Polymorphism, Single Nucleotide
Gene Frequency

Source PubMed

Download CSV of topics

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130379233Levels of primaquine and carboxyprimaquine in patients with malaria vivax from the Brazilian Amazon basin.Rev Inst Med Trop Sao Paulo2018https://conductscience.org/library/papers/30379233PubMed
230706164Effects of MAO-A and CYP450 on primaquine metabolism in healthy volunteers.Parasitol Res2019https://conductscience.org/library/papers/30706164PubMed
329390987CYP2D6 activity and the risk of recurrence of Plasmodium vivax malaria in the Brazilian Amazon: a prospective cohort study.Malar J2018https://conductscience.org/library/papers/29390987PubMed
433529838Primaquine for Plasmodium vivax radical cure: What we do not know and why it matters.Int J Parasitol Drugs Drug Resist2021https://conductscience.org/library/papers/33529838PubMed
523782898The metabolism of primaquine to its active metabolite is dependent on CYP 2D6.Malar J2013https://conductscience.org/library/papers/23782898PubMed
625329392Distribution of CYP2D6 alleles and phenotypes in the Brazilian population.PLoS One2014https://conductscience.org/library/papers/25329392PubMed
732021383Pharmacogene Variation in Thai Plasmodium vivax Relapse Patients Treated with a Combination of Primaquine and Chloroquine.Pharmgenomics Pers Med2020https://conductscience.org/library/papers/32021383PubMed
822856549CYP450 phenotyping and accurate mass identification of metabolites of the 8-aminoquinoline, anti-malarial drug primaquine.Malar J2012https://conductscience.org/library/papers/22856549PubMed
927093859Differential kinetic profiles and metabolism of primaquine enantiomers by human hepatocytes.Malar J2016https://conductscience.org/library/papers/27093859PubMed
1012815363Pharmacogenomics of human UDP-glucuronosyltransferase enzymes.Pharmacogenomics J2003https://conductscience.org/library/papers/12815363PubMed
1124088113Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria.N Engl J Med2013https://conductscience.org/library/papers/24088113PubMed
1232122891Novel Insights into Plasmodium vivax Therapeutic Failure: CYP2D6 Activity and Time of Exposure to Malaria Modulate the Risk of Recurrence.Antimicrob Agents Chemother2020https://conductscience.org/library/papers/32122891PubMed
1319214141Association of MAOA gene functional promoter polymorphism with CSF dopamine turnover and atypical depression.Pharmacogenet Genomics2009https://conductscience.org/library/papers/19214141PubMed
1434474178Plasmodium vivax pre-erythrocytic stages and the latent hypnozoite.Parasitol Int2021https://conductscience.org/library/papers/34474178PubMed
1535452835Effects of CYP2D6 genotypes on Plasmodium vivax recurrence after primaquine treatment: A meta-analysis.Travel Med Infect Dis2022https://conductscience.org/library/papers/35452835PubMed
1627030414Variation in relapse frequency and the transmission potential of Plasmodium vivax malaria.Proc Biol Sci2016https://conductscience.org/library/papers/27030414PubMed
1738667528Aggressiveness in Italian Children with ADHD: MAOA Gene Polymorphism Involvement.Diseases2024https://conductscience.org/library/papers/38667528PubMed
1830103751
Metabolism of primaquine in normal human volunteers: investigation of phase I and phase II metabolites from plasma and urine using ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry.
Malar J2018https://conductscience.org/library/papers/30103751PubMed
1916409140Pharmacogenomics and individualized drug therapy.Annu Rev Med2006https://conductscience.org/library/papers/16409140PubMed
2027388693Prediction of CYP2D6 phenotype from genotype across world populations.Genet Med2017https://conductscience.org/library/papers/27388693PubMed

See all 40 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
42888416CYP3A and CYP2D6 variability in antimalarial pharmacokinetics and pharmacogenetics across populations: a narrative review.Malar J2026https://conductscience.org/library/papers/42888416PubMed
42484259The Landscape of Malaria in a Five-Decade Institution in the State of Amazonas: Historical Trends, Scientific Contributions, and Research Priorities.Rev Soc Bras Med Trop2026https://conductscience.org/library/papers/42484259PubMed
42291620Investigation of Pharmacogenomic Variants in the CYP (P450) Family in Native American Populations of the Brazilian Amazon.Int J Genomics2026https://conductscience.org/library/papers/42291620PubMed
42037398Differential impact of Tafenoquine and Primaquine on Plasmodium vivax recurrence: the role of CYP2D6 variants.Antimicrob Agents Chemother2026https://conductscience.org/library/papers/42037398PubMed
41894411Reduced cytochrome P-450 (CYP) 2D6 activity and Plasmodium vivax malaria risk in Amazonians: A retrospective, population-based cohort study.PLoS Negl Trop Dis2026https://conductscience.org/library/papers/41894411PubMed
41806469The evolving landscape of pharmacogenomics: Current achievements and future directions.Pharmacol Rev2026https://conductscience.org/library/papers/41806469PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40316617

GET https://conductscience.org/api/papers/v1/40316617/references?page=2